The influence of antibiotics and statins on inflammation in coronary disease
Author(s) -
Radan Stojanović,
Zorana Vasiljević,
Milica Prostran,
Mina Radovanović,
Branislav Stefanović,
Nebojša Radovanović,
Jelena Janković,
Mirko Lakićević,
Predrag Mitrović,
Ratko Lasica,
Zorica Nesic,
Zoran Todorović,
Marina Stojanov
Publication year - 2005
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp0509661s
Subject(s) - inflammation , antibiotics , medicine , disease , coronary heart disease , hydroxymethylglutaryl coa reductase inhibitors , statin , microbiology and biotechnology , biology
Cardiovascular system diseases are the leading cause of death in developed countries. According to the World Health Organization data, coronary artery disease is responsible for death of over seven million people per year, while only in the United States about two million patients are hospitalized with the diagnosis of acute coronary syndrome (acute myocardial infarction or unstable angina). The main cause of these diseases is arteriosclerosis. The arteriosclerotic process in the big arterial blood vessels begins very early, already in childhood. Risk factors for arteriosclerosis are: hypercholesterolemia, hypertension, diabetes mellitus, obesity, smoking and physical inactivity. The main mechanism is a modest, chronic inflammative reaction as a response to the blood vessel damage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom